Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsScientists made a comprehensive review on the outcomes resulted from the combination of CAR T-cell immunotherapy and oncolytic virotherapy for the treatment of solid cancers.
[Cancer Gene Therapy]
6445212 TT6XP2R2 items 1 apa 0 default asc 1 163715 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-73c2102464936acd9759cd82641df8cf%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22TT6XP2R2%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rezaei%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-22%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ERezaei%2C%20R.%2C%20Esmaeili%20Gouvarchin%20Ghaleh%2C%20H.%2C%20Farzanehpour%2C%20M.%2C%20Dorostkar%2C%20R.%2C%20Ranjbar%2C%20R.%2C%20Bolandian%2C%20M.%2C%20Mirzaei%20Nodooshan%2C%20M.%2C%20%26amp%3B%20Ghorbani%20Alvanegh%2C%20A.%20%282021%29.%20Combination%20therapy%20with%20CAR%20T%20cells%20and%20oncolytic%20viruses%3A%20a%20new%20era%20in%20cancer%20immunotherapy.%20%3Ci%3ECancer%20Gene%20Therapy%3C%5C%2Fi%3E%2C%201%26%23x2013%3B14.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41417-021-00359-9%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41417-021-00359-9%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DTT6XP2R2%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Combination%20therapy%20with%20CAR%20T%20cells%20and%20oncolytic%20viruses%3A%20a%20new%20era%20in%20cancer%20immunotherapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramazan%22%2C%22lastName%22%3A%22Rezaei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hadi%22%2C%22lastName%22%3A%22Esmaeili%20Gouvarchin%20Ghaleh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahdieh%22%2C%22lastName%22%3A%22Farzanehpour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruhollah%22%2C%22lastName%22%3A%22Dorostkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reza%22%2C%22lastName%22%3A%22Ranjbar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masoumeh%22%2C%22lastName%22%3A%22Bolandian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Majid%22%2C%22lastName%22%3A%22Mirzaei%20Nodooshan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akbar%22%2C%22lastName%22%3A%22Ghorbani%20Alvanegh%22%7D%5D%2C%22abstractNote%22%3A%22Chimeric%20antigen%20receptor%20%28CAR%29%20T-cell%20therapy%20is%20an%20encouraging%20and%20fast-growing%20platform%20used%20for%20the%20treatment%20of%20various%20types%20of%20tumors%20in%20human%20body.%20Despite%20the%20recent%20success%20of%20CAR%20T-cell%20therapy%20in%20hematologic%20malignancies%2C%20especially%20in%20B-cell%20lymphoma%20and%20acute%20lymphoblastic%20leukemia%2C%20the%20application%20of%20this%20treatment%20approach%20in%20solid%20tumors%20faced%20several%20obstacles%20resulted%20from%20the%20heterogeneous%20expression%20of%20antigens%20as%20well%20as%20the%20induction%20of%20immunosuppressive%20tumor%20microenvironment.%20Oncolytic%20virotherapy%20%28OV%29%20is%20a%20new%20cancer%20treatment%20modality%20by%20the%20use%20of%20competent%20or%20genetically%20engineered%20viruses%20to%20replicate%20in%20tumor%20cells%20selectively.%20OVs%20represent%20potential%20candidates%20to%20synergize%20the%20current%20setbacks%20of%20CAR%20T-cell%20application%20in%20solid%20tumors%20and%20then%20and%20overcome%20them.%20As%20well%2C%20the%20application%20of%20OVs%20gives%20researches%20the%20ability%20to%20engineer%20the%20virus%20with%20payloads%20in%20the%20way%20that%20it%20selectively%20deliver%20a%20specific%20therapeutic%20agents%20in%20tumor%20milieu%20to%20reinforce%20the%20cytotoxic%20activity%20of%20CAR%20T%20cells.%20Herein%2C%20we%20made%20a%20comprehensive%20review%20on%20the%20outcomes%20resulted%20from%20the%20combination%20of%20CAR%20T-cell%20immunotherapy%20and%20oncolytic%20virotherapy%20for%20the%20treatment%20of%20solid%20cancers.%20In%20the%20current%20study%2C%20we%20also%20provided%20brief%20details%20on%20some%20challenges%20that%20remained%20in%20this%20field%20and%20attempted%20to%20shed%20a%20little%20light%20on%20the%20future%20perspectives.%22%2C%22date%22%3A%222021-06-22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41417-021-00359-9%22%2C%22ISSN%22%3A%221476-5500%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41417-021-00359-9%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-06-22T16%3A18%3A59Z%22%7D%7D%5D%7D
Rezaei, R., Esmaeili Gouvarchin Ghaleh, H., Farzanehpour, M., Dorostkar, R., Ranjbar, R., Bolandian, M., Mirzaei Nodooshan, M., & Ghorbani Alvanegh, A. (2021). Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy. Cancer Gene Therapy, 1–14. https://doi.org/10.1038/s41417-021-00359-9 Cite
